Massive subfascial hematoma after alteplase therapy for acute myocardial infarction

American Journal of the Medical Sciences

Volumn 317, Issue 1, 1999, Pages 53-54

  Khanlou, Homayoun ^a   Malhotra, Gaurav ^a   Khanlou, Nehgar ^a   Eiger, Glenn ^a   Frechie, Peter ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Alteplase; Myocardial infarction; Subfascial hematoma

Indexed keywords

ALTEPLASE; HEMOGLOBIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; CASE REPORT; ECCHYMOSIS; FASCIA; FEMALE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

EID: 0032992764     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40470-7     Document Type: Article

References (6)

1. Wagstaff AJ, Gillis JC, Goa KL. Alteplase: a reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction. Drugs. 1995;50:289-326.
2. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-82.
3. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after myocardial infarction. N Engl J Med. 1993;329:1615-22. [Erratum, N Engl J Med. 1994;330:516.]
4. The GUSTO III Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med. 1997;337:1118-23.
5. Burnside J, Costello JM Jr, Angelastro NJ, Blankenship J. Forearm compartment syndrome following thrombolytic therapy for acute myocardial infarction. Clin Cardiol. 1994;17:345-7.
6. McMechan SR, Morrow B, Campbell NP. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction. Br Heart J. 1995;74:205.